Role of hypoxia and constitutionally different resistance to hypoxia/stress as the determiners of individual profile of cytochrome P450 isozyme activity

General Pharmacology

Volumn 33, Issue 4, 1999, Pages 355-361

  Bayanov, A A ^a,b   Brunt, A R ^b  

^a NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Laboratory of Psychopharmacology   (Russian Federation)

Author keywords

Cytochrome P450; Hypoxia; Individual resistance; Liver ischemia

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HYPOXIA; LIVER ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANOXIA; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; ISCHEMIA; ISOENZYMES; LIVER; MALE; MICROSOMES, LIVER; OXIDOREDUCTASES; RATS; RATS, WISTAR; STRESS;

EID: 0032831313     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00288-2     Document Type: Article

References (41)

1. Agadzhanyan N.A., Sorokin L.V., Tambovtsev E.P., Torshin V.I. The criterions of individual and populational resistance to acute hypoxia. Bull Experim Biol and Med. 120:1995;239-241.
2. Aitio A., Aitio M.-L., Camus A.-M., Card E., Bartsch H. Cytochrome P450 isozyme pattern in related to individual susceptibility to diethylnitrozamine-induced liver cancer in rats. Jap J Cancer Res. 82:1991;146-156.
3. Barakat M., du Souich P. Effect of nifedipine on the elimination of theophylline in the rabbit subjected to hypoxia or to an inflammatory reaction. J Pharm Pharmacol. 48:1996;906-910.
4. Bayanov A.A., Grek O.R. Pathogenesis, prevention and therapy of hypoxic and ischemic states. 1996;6-18 Medical Institute Press, Novosibirsk, Russia.
5. Bayanov A.A. Minor activation of cytochromes P450 1A1, 1A2 by phenobarbital. regulatory role of "hyperoxic" factor FASEB J. 11:1997;295.
6. Berezovsky V.A. Hypoxia and individual features of reactivity. 1978;215 Naukova Dumka, Kiev, Ukraine.
7. Brunt A.R., Bayanov A.A., Grek O.R. Interindividual differences of hepatic cytochrome P450 2B1 expression. influence of hypoxia FASEB J. 11:1997;266.
8. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparanta T., Mayer R.T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues. a series of substrates to distinguish between different induced cytochromes P450 Biochem Pharmacol. 34:1985;3337-3345.
9. Costa L.E., Llesuy S., Boveris A. Active oxygen species in the liver in rats submitted to chronic hypobaric hypoxia. Am J Physiol. 264:1993;1395-1400.
10. Eichelbaum M., Koremer N.K., Mikus G. Genetically determined differences in drug metabolism as a risk factor in drug toxicity. Toxicol Lett. 64:1992;115-122.
11. Gorchakova L.A. A study of the relation between rats resistance to acute hypoxic hypoxia and activity of the liver microsomal oxidation system. Physiol J Ukr. 33:1987;53-58.
12. Gromova O.A., Polyakova N.E., Kozlovskaya N.E., Vavilin V.A., Grishanova A.Y., Kolpakov A.R., Lyakhovich V.V. Effect of exposure to cold on cytochromes P450 and monooxygenase activities in rat liver microsomes. J Basic Clin Physiol and Pharmacol. 3:1992;189.
13. Guengerich F.P. Cytochrome P450. 1995;473-535 Plenum Press, New York, NY.
14. Hochachka P.W. Defense strategies against hypoxia and hypothermia. Science. 231:1986;234-241.
15. Horbach G.J.M.J., Venkatraman J.T., Fernandes G. Food restriction prevents loss of isosafrole inductible cytochrome P450 mRNA and enzyme levels in aging rats. FASEB J. 4:1990;1571.
16. Imai Y., Ito A., Sato R. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. J Biochem. 60:1966;417-425.
17. Jiang X.-M., Cantrill E., Farrell G.C., Murrey M. Pretranslational down-regulation of male specific hepatic P450s after portal bypass. Biochem Pharmacol. 48:1994;701-708.
18. Jones D.P., Aw T.Y., Shan X. Drug metabolism and toxicity during hypoxia. Drug Metab Rev. 20:1989;247-260.
19. Konstantinopolsky M.A., Surkova L.A., Tyurina I.V., Sudakov S.K. Evaluation of Wistar rats, individual sensitivity to the development of morphine dependence. Experim Clin Pharmacol. 55:1992;9-11.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
21. Lukyanova L.D., Dudchenko A.M., Belousova V.V. Influence of different oxygen concentrations on the ATP content in isolated hepatocytes of adapted and inadapted to hypoxia rats. Bull Experim Biol and Med. 118:1994;576-581.
22. Mufti N.A., Shuler M.L. Induction of cytochrome P450 1A1 activity in response to sublethal stresses in microcarrier-attached Hep G2 cells. Biotechnol Prog. 11:1995;659-663.
23. Mufti N.A., Shuler M.L. Possible role of arachidonic acid in stress-induced cytochrome P450 1A1 activity. Biotechnol Prog. 12:1996;847-854.
24. Oesch-Bartlomowicz B., Oesch F. Phosphorylation of cytochrome P450 isoenzymes in intact hepatocytes and its importance for their function in metabolic process. Arch Toxicol. 64:1990;257-261.
25. Ohmori S., Misaizu T., Nakamura T., Takano N., Kitagawa H., Kitada M. Differential role in lipid peroxidation between rat P450 1A1 and P450 1A2. Biochem Pharmacol. 46:1993;55-60.
26. Okamoto T., Mitsuhashi M., Fujita I., Sindhu R.K., Kikkawa Y. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia. Biochem Biophys Res Commun. 197:1993;878-884.
27. Omura T., Sato R. The carbon monoxidebinding pigment of liver microsomes 1. Evidence for its hemoprotein nature. 2. Solubulization purification and properties. J Biol Chem. 239:1964;2370-2385.
28. Park G.R., Pichard L., Tinel M., Larroque C., Elston A., Domerque J., Dexione B., Maurel P. What changed drug metabolism in critically ill patients? Two preliminary studies in isolated human hepatocytes. Anaesthesia. 49:1994;188-189.
29. Perramon A., Stupfel M., Merat P., Demarta-Pesce V.H., Gourlet V., Tiarry H. Evidence of genetic differences in acute hypoxia survival. Aviat Space Environ Med. 54:1983;127-131.
30. Proulx M., du Souich P. Acute moderate hypoxia in conscious rabbits - effect on hepatic cytochrome P450 and reactive oxygen species. J Pharm Pharmacol. 47:1995;392-397.
31. Pyerin W., Taniguchi N. Phosphorylation of cytochrome P450 in intact cells. J Cancer Res and Clin Oncol. 115:1989;41.
32. Salonpaa P., Pelkonen O., Kojo A., Pasanen M., Negishi M., Raunio H. Cytochrome P450 2A5 expression and inducibility by phenobarbital immodulated by cAMP in mouse primary hepatocytes. Biochem Biophys Res Commun. 205:1994;631-637.
33. Sevanian A., Nordenbrand K., Kim E., Ernster L., Hochstein P. Mocrosomal lipid peroxidation. the role of NADPH-cytochrome P450-reductase and cytochrome P450 Free Radic Biol and Med. 8:1990;145-152.
34. Shan X., Aw T.Y., Smith E.R., Ingelman-Sundberg M., Mannervik B., Iyanagi T., Jones D.P. Effect of chronic hypoxia on detoxication enzymes in rat liver. Biochem Pharmacol. 43:1992;2421-2426.
35. Sharapov V.I., Kolpakov M.A., Grek O.R., Faibushevich A.A. Comparative activity of antipyrine, nifedipine and diazepam metabolism in Wistar rats under experimental myocardial infarction. J Basic Clin Physiol and Pharmacol. 3:1992;277.
36. Ueng T.H., Ueng Y.-F., Chen T.L., Park S.S., Iwasaki M., Guengerich F.P. Induction of cytochrome P450-dependent monooxygenases in hamster tissues by fasting. Toxicol Appl Pharmacol. 119:1993;66-73.
37. Vesell E.S. Genetic and environmental factors affecting drug disposition in man. Clin Pharmacol Ther. 22:1977;659-679.
38. Videla L.A. Respective roles of free radicals and energy supply in hypoxic rat liver injury after reoxygenation. Free Rad Res Commun. 14:1991;209-215.
39. Woodrooffe A.J.M., Bayliss M.K., Park G.R. The effects of hypoxia on drug-metabolizing enzymes. Drug Metab Rev. 27:1995;471-495.
40. Wortelboer H.M., de Kruif C.A., van Iarsel A.A.J., Falke H.E., Noordhoek J., Blaauboer B.J. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Biochem Pharmacol. 42:1991;381-390.
41. Yang C.S., Yoo J.S.H., Ishizaki H., Hong J. Cytochrome P450 IIE1. roles in nitrosoamine metabolism and mechanism of regulation Drug Metab Rev. 22:1990;147-159.